Cardiac Specific Transgenic Inhibition of Nuclear Factor-Kappab (Nf-Kb) Mitigates Adverse Cardiac Remodeling And Ameliorates Cardiac Dysfunction In Doxorubicin-Induced Cardiomyopathy.